SCHEMBL18113992

SCHEMBL18113992

NC[C@@H]1CC(=O)[C@@H]2CN1C(=O)N2OS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18113991 0.89 — —
SCHEMBL19999936 0.86 — —
SCHEMBL19999929 0.81 — —
SCHEMBL18114011 0.78 — —
SCHEMBL18113998 0.76 ACACB (0.33) —
SCHEMBL18059669 0.76 — —
SCHEMBL16644682 0.76 — —
SCHEMBL16637915 0.76 — —
SCHEMBL16637916 0.76 — —
Trifluoroacetic Acid SCHEMBL18113990 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3277685-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2021-01-13 — — EP disclosed
US-10570131-B2 Heterocyclic compounds and their use in preventing or treating bacterial infections MUTABILIS (FR) 2020-02-25 — — US disclosed
US-20180086760-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2018-03-29 — — US disclosed
EP-3277685-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS Mutabilis (FR) 2018-02-07 — — EP disclosed
WO-2016156344-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2016-10-06 — — WO disclosed
WO-2016156346-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS MUTABILIS (FR) 2016-10-06 — — WO disclosed
Send feedback